ConsultantLive

An expert discusses comprehensive advancements in atopic dermatitis management, emphasizing early and accurate diagnosis, patient-centered assessment, practical severity evaluation tools, and proactive, personalized treatment strategies that prioritize updated non-steroidal therapies; the importance of careful topical steroid use; holistic patient education; coordinated care with timely dermatology referrals; and addressing diverse presentations—especially in underserved and darker-skinned populations—to improve long-term outcomes and quality of life.

Eingun James Song, MD, FAAD discusses how recent revolutionary non-steroidal topical therapies introduced in 2025 have transformed atopic dermatitis treatment by providing effective alternatives to corticosteroids, enabling proactive maintenance strategies that prevent flares rather than simply treating them reactively.

A panelist discusses how fresh approaches in atopic dermatitis management empower primary care providers to address both the physical and psychosocial burdens of the disease through early diagnosis, patient education, and emerging treatment options.

Shawn Kwatra, MD​ and Carolyn Stolte, CRNP discuss how, primary care providers can effectively diagnose, assess, and manage atopic dermatitis by recognizing diverse clinical presentations, utilizing appropriate severity scales, navigating treatment options—including newer non-steroidal agents—and balancing long-term steroid use with patient education and personalized care.

Lisa Swanson, MD​, discusses comprehensive management strategies for atopic dermatitis, covering diagnosis, treatment selection criteria, topical therapies (including PDE4 inhibitors, JAK inhibitors, and AhR agonists), age-specific considerations, specialty care coordination, and practical application through case studies to optimize patient outcomes in clinical practice.

Aneesa Das, MD, and Jeanne Caligiuri, MD, examine the comprehensive landscape of obstructive sleep apnea, from its fundamental pathophysiology and health impacts to diagnostic approaches and systemic barriers that challenge effective identification and treatment of this prevalent sleep disorder.

Medha Munshi, MD, and Conan Tu, MD, MBA, DACD, BC-ADM, present patient cases, review clinical trial data, and provide comprehensive insights on the treatment of older adult patients with type 2 diabetes.

Medha Munshi, MD, and John E Anderson, MD,discuss comprehensive strategies for personalized diabetes management in older adults, covering case studies, treatment adjustments, combination therapies, and deprescribing, with a focus on tailoring care for effective geriatric diabetes care.

Medha Munshi, MD, and Javier Morales, MD, FACP, FACE, emphasize the significance of personalized diabetes management, emphasizing age and other patient-specific factors as crucial considerations for optimizing care.

Jennifer D Goldman, RPh, PharmD, CDCES, BC-ADM, FCCP​, and Guillermo E. Umpierrez, MD, CDCES, FACE, MACP​, break down the use of CGMs (continuous glucose monitoring) for patients treated in primary care.

Medha Munshi, MD, and James Bailey, III, MD, FACE, ECNU, discuss the management of type 2 diabetes in older adult patient populations, focusing on tailored treatment approaches, the benefits of combination therapy, and the process of deprescribing medications when necessary.

An expert in the management of liver conditions provides an overview of cirrhosis, including its epidemiology and the distinction between compensated and decompensated forms. Patient cases are reviewed to highlight hepatic encephalopathy as a complication and how to manage and prevent the recurrence of this condition.

Experts in vaccination uptake strategies discuss the upcoming flu season, emphasizing the significance of timely vaccination, the range of available vaccine types, and the role clinicians and pharmacists play in the educating patients about the importance of being vaccinated.